Try our beta test site
246 studies found for:    Open Studies | "Thyroid Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting NIRF for Parathyroid Visualization: a Pilot Study
Condition: Thyroid Disease
Intervention: Device: NIRF imaging in thyroid surgery
22 Not yet recruiting Effect of Intraoperative Nerve Monitoring on Voice Quality During Thyroid Surgery
Condition: Thyroid
Intervention: Procedure: Intraoperative nerve monitoring
23 Recruiting Natural History Study of Children and Young Adults With Medullary Thyroid Cancer
Condition: Medullary Thyroid Carcer
Intervention:
24 Recruiting The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Dietary Supplement: thymus honey mouthwash
25 Available The Multi-Center Study of Shear Wave Elastography on Thyroid Nodules
Condition: Thyroid Nodules
Intervention: Device: SWE
26 Recruiting Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
Condition: Thyroid Cancer
Interventions: Drug: Vemurafenib (All Groups);   Drug: Vemurafenib (Post Surgery) - Group A + C;   Other: Post Surgery - Group B
27 Recruiting Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Intervention: Drug: Lenvatinib
28 Recruiting Treatment of Benign Thyroid Nodules With FastScan HIFU
Condition: Benign Thyroid Nodules
Intervention: Device: Echopulse
29 Recruiting A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Interventions: Drug: Cabozantinib (XL184) 140 mg;   Drug: Cabozantinib (XL184) 60 mg;   Drug: Placebo tablet;   Drug: Placebo capsule
30 Recruiting Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
Condition: Thyroid Neoplasms
Intervention: Drug: Lenvatinib
31 Recruiting Institut Paoli Calmettes Thyroid Cancer Database
Condition: Thyroid Neoplasms
Intervention: Other: Data collection
32 Recruiting A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
Conditions: Differentiated Thyroid Cancer (DTC);   Poorly Differentiated Thyroid Cancer
Intervention: Drug: Cabozantinib
33 Recruiting Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer
Condition: Differentiated Thyroid Cancer
Interventions: Drug: Apatinib Oral Tablet;   Drug: Placebo Oral Tablet
34 Recruiting Validation of a Multi-Genetic Test for the Diagnosis of Indeterminate Thyroid Nodules
Condition: Indeterminate Thyroid Cytology
Intervention:
35 Recruiting Measuring Patient Expectations for Thyroid Surgery
Condition: Thyroid Cancer
Interventions: Behavioral: patient interviews;   Behavioral: CITSAV survey
36 Recruiting Study of Apatinib in Patients With Differentiated Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: Apatinib
37 Recruiting I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer
Condition: Differentiated Thyroid Carcinoma
Interventions: Radiation: Radioiodine I-131;   Radiation: I-124
38 Recruiting Gemcitabine - Oxaliplatin for Advanced Refractory Thyroid Cancer Patients: a Phase II Study
Condition: Thyroid Cancer
Intervention: Drug: gemcitabine -oxaliplatine combination
39 Not yet recruiting A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery
Condition: Thyroid Gland Diseases
Interventions: Drug: CTC;   Drug: G-PERT
40 Recruiting Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
Condition: Thyroid Neoplasms
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.